Keith Katkin Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Keith Katkin.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Keith Katkin. Keith Katkin is President and CEO in AVANIR PHARMACEUTICALS, INC. ($AVNR).
Latest Insider Trading Transactions of Keith Katkin
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 01 2014 | AVNR | AVANIR PHARMACEUTI ... | Katkin Keith | President and CEO | Sell | S | 5.26 | 9,670 | 50,864 | 760,412 | 770.1 K to 760.4 K (-1.26 %) |
Jul 10 2014 | AVNR | AVANIR PHARMACEUTI ... | Katkin Keith | President and CEO | Grant | A | 0.00 | 20,000 | 0 | 770,082 | 750.1 K to 770.1 K (+2.67 %) |
May 30 2014 | AVNR | AVANIR PHARMACEUTI ... | Katkin Keith | President and CEO | Option Exercise | M | 0.88 | 317,212 | 279,147 | 0 | |
May 30 2014 | AVNR | AVANIR PHARMACEUTI ... | Katkin Keith | President and CEO | Option Exercise | M | 1.29 | 75,000 | 96,750 | 55,960 | |
May 30 2014 | AVNR | AVANIR PHARMACEUTI ... | Katkin Keith | President and CEO | Sell | S | 5.01 | 442,212 | 2,215,482 | 750,082 | 1.2 M to 750.1 K (-37.09 %) |
May 22 2014 | AVNR | AVANIR PHARMACEUTI ... | Katkin Keith | President and CEO | Option Exercise | D | 2.84 | 26,250 | 74,550 | 125,000 | |
Feb 14 2014 | AVNR | AVANIR PHARMACEUTI ... | Katkin Keith | President and CEO | Grant | A | 0.00 | 97,250 | 0 | 800,082 | 702.8 K to 800.1 K (+13.84 %) |
Feb 14 2014 | AVNR | AVANIR PHARMACEUTI ... | Katkin Keith | President and CEO | Grant | A | 0.00 | 257,125 | 0 | 702,832 | 445.7 K to 702.8 K (+57.69 %) |
Dec 20 2013 | AVNR | AVANIR PHARMACEUTI ... | Katkin Keith | President and CEO | Sell | S | 2.67 | 29,515 | 78,935 | 445,707 | 475.2 K to 445.7 K (-6.21 %) |
Dec 17 2013 | AVNR | AVANIR PHARMACEUTI ... | Katkin Keith | President and CEO | Option Exercise | A | 2.84 | 151,250 | 429,550 | 151,250 | |
Nov 05 2013 | AVNR | AVANIR PHARMACEUTI ... | Katkin Keith | President and CEO | Sell | S | 4.14 | 4,385 | 18,138 | 475,222 | 479.6 K to 475.2 K (-0.91 %) |
Aug 02 2013 | AVNR | AVANIR PHARMACEUTI ... | Katkin Keith | President and CEO | Sell | S | 4.84 | 15,500 | 74,981 | 479,607 | 495.1 K to 479.6 K (-3.13 %) |
May 17 2013 | AVNR | AVANIR PHARMACEUTI ... | Katkin Keith | President and CEO | Option Exercise | M | 0.88 | 159,638 | 140,481 | 53,212 | |
May 17 2013 | AVNR | AVANIR PHARMACEUTI ... | Katkin Keith | President and CEO | Option Exercise | M | 0.53 | 55,800 | 29,574 | 0 | |
May 17 2013 | AVNR | AVANIR PHARMACEUTI ... | Katkin Keith | President and CEO | Sell | S | 3.26 | 215,438 | 702,220 | 495,107 | 710.5 K to 495.1 K (-30.32 %) |
May 17 2013 | AVNR | AVANIR PHARMACEUTI ... | Katkin Keith | President and CEO | Buy | M | 0.88 | 159,638 | 140,481 | 710,545 | 550.9 K to 710.5 K (+28.98 %) |
May 17 2013 | AVNR | AVANIR PHARMACEUTI ... | Katkin Keith | President and CEO | Buy | M | 0.53 | 55,800 | 29,574 | 550,907 | 495.1 K to 550.9 K (+11.27 %) |
May 17 2013 | AVNR | AVANIR PHARMACEUTI ... | Katkin Keith | President and CEO | Sell | S | 3.26 | 35,000 | 114,093 | 495,107 | 530.1 K to 495.1 K (-6.60 %) |
Dec 05 2012 | AVNR | AVANIR PHARMACEUTI ... | Katkin Keith | President and CEO | Sell | S | 2.55 | 18,250 | 46,457 | 119,482 | 137.7 K to 119.5 K (-13.25 %) |
Jun 27 2012 | AVNR | AVANIR PHARMACEUTI ... | Katkin Keith | President and CEO | Sell | S | 3.50 | 190,125 | 664,791 | 137,732 | 327.9 K to 137.7 K (-57.99 %) |
Mar 07 2012 | AVNR | AVANIR PHARMACEUTI ... | Katkin Keith | President and CEO | Buy | P | 2.61 | 10,000 | 26,093 | 327,857 | 317.9 K to 327.9 K (+3.15 %) |
Dec 16 2011 | AVNR | AVANIR PHARMACEUTI ... | Katkin Keith | President and CEO | Option Exercise | A | 1.85 | 337,500 | 624,375 | 337,500 | |
Dec 16 2011 | AVNR | AVANIR PHARMACEUTI ... | Katkin Keith | President and CEO | Grant | A | 0.00 | 97,000 | 0 | 317,857 | 220.9 K to 317.9 K (+43.92 %) |
Dec 16 2011 | AVNR | AVANIR PHARMACEUTI ... | Katkin Keith | President and CEO | Grant | A | 0.00 | 30,000 | 0 | 220,857 | 190.9 K to 220.9 K (+15.72 %) |
Dec 06 2011 | AVNR | AVANIR PHARMACEUTI ... | Katkin Keith | President and CEO | Sell | S | 2.37 | 17,495 | 41,421 | 190,857 | 208.4 K to 190.9 K (-8.40 %) |
Nov 18 2011 | AVNR | AVANIR PHARMACEUTI ... | Katkin Keith | President and CEO | Option Exercise | M | 0.88 | 106,425 | 93,654 | 319,275 | |
Nov 18 2011 | AVNR | AVANIR PHARMACEUTI ... | Katkin Keith | President and CEO | Option Exercise | M | 0.53 | 2,587 | 1,371 | 139,500 | |
Nov 18 2011 | AVNR | AVANIR PHARMACEUTI ... | Katkin Keith | President and CEO | Option Exercise | M | 0.53 | 109,013 | 57,777 | 142,087 | |
Nov 18 2011 | AVNR | AVANIR PHARMACEUTI ... | Katkin Keith | President and CEO | Sell | S | 2.59 | 109,012 | 282,657 | 208,352 | 317.4 K to 208.4 K (-34.35 %) |
Nov 18 2011 | AVNR | AVANIR PHARMACEUTI ... | Katkin Keith | President and CEO | Buy | M | 0.88 | 106,425 | 93,654 | 317,364 | 210.9 K to 317.4 K (+50.45 %) |
Nov 18 2011 | AVNR | AVANIR PHARMACEUTI ... | Katkin Keith | President and CEO | Buy | M | 0.53 | 2,587 | 1,371 | 210,939 | 208.4 K to 210.9 K (+1.24 %) |
Nov 18 2011 | AVNR | AVANIR PHARMACEUTI ... | Katkin Keith | President and CEO | Sell | S | 2.59 | 109,013 | 282,300 | 208,352 | 317.4 K to 208.4 K (-34.35 %) |
Nov 18 2011 | AVNR | AVANIR PHARMACEUTI ... | Katkin Keith | President and CEO | Buy | M | 0.53 | 109,013 | 57,777 | 317,365 | 208.4 K to 317.4 K (+52.32 %) |
Page: 1